These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 35557845)

  • 1. Benefits of Surgical Over Medical Treatment for Unilateral Primary Aldosteronism.
    Ahmed S; Hundemer GL
    Front Endocrinol (Lausanne); 2022; 13():861581. PubMed ID: 35557845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism.
    Wachtel H; Fraker DL
    Curr Cardiol Rep; 2021 Jun; 23(7):89. PubMed ID: 34081226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-Dependent Risk of Atrial Fibrillation in Patients With Primary Aldosteronism After Medical or Surgical Treatment Initiation.
    Kim KJ; Hong N; Yu MH; Lee H; Lee S; Lim JS; Rhee Y
    Hypertension; 2021 Jun; 77(6):1964-1973. PubMed ID: 33866798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism.
    Katabami T; Fukuda H; Tsukiyama H; Tanaka Y; Takeda Y; Kurihara I; Ito H; Tsuiki M; Ichijo T; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Sone M; Inagaki N; Takahashi K; Fujita M; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Yamamoto K; Ogo A; Yanase T; Suzuki T; Naruse M;
    J Hypertens; 2019 Jul; 37(7):1513-1520. PubMed ID: 31145370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism.
    Satoh M; Maruhashi T; Yoshida Y; Shibata H
    Hypertens Res; 2019 Jun; 42(6):817-824. PubMed ID: 30948836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years.
    Wu VC; Chueh SJ; Chen L; Chang CH; Hu YH; Lin YH; Wu KD; Yang WS;
    J Hypertens; 2017 Aug; 35(8):1698-1708. PubMed ID: 28661412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies.
    Marzano L; Colussi G; Sechi LA; Catena C
    Am J Hypertens; 2015 Mar; 28(3):312-8. PubMed ID: 25336498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
    Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineralocorticoid Receptor Antagonists in Primary Aldosteronism.
    Stavropoulos K; Papadopoulos C; Koutsampasopoulos K; Lales G; Mitas C; Doumas M
    Curr Pharm Des; 2018; 24(46):5508-5516. PubMed ID: 30854950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism.
    Hundemer GL; Vaidya A
    Eur J Endocrinol; 2020 Dec; 183(6):R185-R196. PubMed ID: 33077688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment.
    Hundemer GL
    Curr Cardiol Rep; 2019 Jul; 21(9):93. PubMed ID: 31352525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery decreases the long-term incident stroke risk in patients with primary aldosteronism.
    Chang YH; Chung SD; Wu CH; Chueh JS; Chen L; Lin PC; Lin YH; Huang KH; Wu VC; Chu TS;
    Surgery; 2020 Feb; 167(2):367-377. PubMed ID: 31676114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Medical Treatment of Primary Aldosteronism.
    Li YJ; Ji ZG; Wen J
    Chin Med Sci J; 2023 Mar; 38(1):49-56. PubMed ID: 36642703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of primary hyperaldosteronism.
    Araujo-Castro M
    Med Clin (Barc); 2020 Oct; 155(7):302-308. PubMed ID: 32586668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism.
    Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
    Hypertension; 2018 Sep; 72(3):658-666. PubMed ID: 29987110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Primary Aldosteronism in Resistant Hypertension.
    Stavropoulos K; Imprialos KP; Patoulias D; Katsimardou A; Doumas M
    Curr Hypertens Rep; 2022 Aug; 24(8):285-294. PubMed ID: 35445928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Larger ascending aorta in primary aldosteronism: a 3-year prospective evaluation of adrenalectomy vs. medical treatment.
    Zavatta G; Di Dalmazi G; Pizzi C; Bracchetti G; Mosconi C; Balacchi C; Pagotto U; Vicennati V
    Endocrine; 2019 Mar; 63(3):470-475. PubMed ID: 30430353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
    Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
    J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness.
    Holaj R; Rosa J; Zelinka T; Štrauch B; Petrák O; Indra T; Šomlóová Z; Michalský D; Novák K; Wichterle D; Widimský J
    J Hypertens; 2015 Apr; 33(4):874-82; discussion 882. PubMed ID: 25490707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.